Annual European Cancer Congress in Madrid : Updates in Non-Small Cell Lung Cancer (NSCLC) Immunotherapy
WebcastFaculty
OVERVIEW
Annual European Cancer Congress in Madrid : Updates in Non-Small Cell Lung Cancer (NSCLC) Immunotherapy is organized by PRIME Oncology and will be held during Oct 10, 2017 - Oct 10, 2018.
The target audience for this medical event is designed to meet the needs of medical oncologists and other healthcare professionals involved in the treatment of patients with lung cancer.
Course Description :
Hear from the experts on the optimal use of targeted therapy for metastatic colorectal cancer (mCRC). Practical challenges like treatment sequence, third-line therapy, and management of high microsatellite instability (MSI-H) will be discussed. A clinical scenario with patient history, laboratory results, and options for next steps in treatment provide commentary and insight for decision making in the care of your patients with mCRC.
Conference Objectives are :
After successful completion of this educational activity, participants should be able to:
• Identify recent and emerging efficacy and safety data for immunotherapeutic strategies for the treatment of non-small cell lung cancer (NSCLC)
• Explain the important features of patient selection for immunotherapies
• Identify strategies to recognize and manage adverse events due to the use of immunotherapies
Additional details will be posted as soon as they are available.
The target audience for this medical event is designed to meet the needs of medical oncologists and other healthcare professionals involved in the treatment of patients with lung cancer.
Course Description :
Hear from the experts on the optimal use of targeted therapy for metastatic colorectal cancer (mCRC). Practical challenges like treatment sequence, third-line therapy, and management of high microsatellite instability (MSI-H) will be discussed. A clinical scenario with patient history, laboratory results, and options for next steps in treatment provide commentary and insight for decision making in the care of your patients with mCRC.
Conference Objectives are :
After successful completion of this educational activity, participants should be able to:
• Identify recent and emerging efficacy and safety data for immunotherapeutic strategies for the treatment of non-small cell lung cancer (NSCLC)
• Explain the important features of patient selection for immunotherapies
• Identify strategies to recognize and manage adverse events due to the use of immunotherapies
Additional details will be posted as soon as they are available.
SPECIALITIES
OncologyImmunotherapiesRELATED ONLINE COURSES
By eMedEd, Inc.
Nov 28, 2024 - Nov 08, 2028 | Text-Based CME
State required course for Connecticut ...
2 Contact Hour
By eMedEd, Inc.
Apr 21, 2022 - Mar 01, 2034 | Webcast
State required course for New Jersey
2 AMA PRA Category 1 Credits™
...
...
Quick Links